A complete opposite finding was published by Corcia et al. In Swedish ALS patients with homozygous SMN2 deletion the duration of the disease was more than 3 months longer compared to a formerly investigated unrelated cohort of French patients. The gene discussed is SMN2; the disease is amyotrophic lateral sclerosis.